TY - JOUR
T1 - The effect of prenatal balanced energy and protein supplementation on gestational weight gain
T2 - An individual participant data meta-analysis in low- and middle-income countries
AU - Wang, Dongqing
AU - Partap, Uttara
AU - Liu, Enju
AU - Costa, Janaína Calu
AU - Cliffer, Ilana R.
AU - Wang, Molin
AU - Nookala, Sudeer Kumar
AU - Subramoney, Vishak
AU - Briggs, Brittany
AU - Ahmed, Imran
AU - Argaw, Alemayehu
AU - Ariff, Shabina
AU - Bhandari, Nita
AU - Chowdhury, Ranadip
AU - Erchick, Daniel
AU - García-Guerra, Armando
AU - Ghaffarpour, Masoumah
AU - Hanley-Cook, Giles
AU - Huybregts, Lieven
AU - Jehan, Fyezah
AU - Kaseb, Fatemeh
AU - Krebs, Nancy F.
AU - Lachat, Carl
AU - Lama, Tsering Pema
AU - Manandhar, Dharma S.
AU - McClure, Elizabeth M.
AU - Moore, Sophie E.
AU - Muhammad, Ameer
AU - Neufeld, Lynnette M.
AU - Prentice, Andrew M.
AU - Quezada-Sánchez, Amado D.
AU - Roberfroid, Dominique
AU - Saville, Naomi M.
AU - Shafiq, Yasir
AU - Shrestha, Bhim P.
AU - Sonko, Bakary
AU - Soofi, Sajid
AU - Taneja, Sunita
AU - Tielsch, James M.
AU - Toe, Laéticia Céline
AU - Valaei, Naser
AU - Fawzi, Wafaie W.
N1 - Publisher Copyright:
© 2025 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2025/2
Y1 - 2025/2
N2 - Background AU Understanding: Please confirm that all heading levels are represented correctly the effects of balanced energy and protein (BEP): supplements on gestational weight gain (GWG) and how the effects differ depending on maternal characteristics and the nutritional composition of the supplements will inform the implementation of prenatal BEP interventions. Methods and findings Individual participant data from 11 randomized controlled trials of prenatal BEP supplements (N = 12,549, with 5,693 in the BEP arm and 6,856 in the comparison arm) in low- and middle-income countries were used. The primary outcomes included GWG adequacy (%) and the estimated total GWG at delivery as continuous outcomes, and severely inadequate (<70% adequacy), inadequate GWG (<90% adequacy), and excessive GWG (>125% adequacy) as binary outcomes; all variables were calculated based on the Institute of Medicine recommendations. Linear and log-binomial models were used to estimate study-specific mean differences or risk ratios (RRs), respectively, with 95% confidence intervals (CIs) of the effects of prenatal BEP on the GWG outcomes. The study-specific estimates were pooled using meta-analyses. Subgroup analyses were conducted by individual characteristics. Subgroup analyses and meta-regression were conducted for study-level characteristics. Compared to the comparison group, prenatal BEP led to a 6% greater GWG percent adequacy (95% CI: 2.18, 9.56; p = 0.002), a 0.59 kg greater estimated total GWG at delivery (95% CI, 0.12, 1.05; p = 0.014), a 10% lower risk of severely inadequate GWG (RR: 0.90; 95% CI: 0.83, 0.99; p = 0.025), and a 7% lower risk of inadequate GWG (RR: 0.93; 95% CI: 0.89, 0.97; p = 0.001). The effects of prenatal BEP on GWG outcomes were stronger in studies with a targeted approach, where BEP supplements were provided to participants in the intervention arm under specific criteria such as low body mass index or low GWG, compared to studies with an untargeted approach, where BEP supplements were provided to all participants allocated to the intervention arm. Conclusions Prenatal BEP supplements are effective in increasing GWG and reducing the risk of inadequate weight gain during pregnancy. BEP supplementation targeted toward pregnant women with undernutrition may be a promising approach to delivering the supplements.
AB - Background AU Understanding: Please confirm that all heading levels are represented correctly the effects of balanced energy and protein (BEP): supplements on gestational weight gain (GWG) and how the effects differ depending on maternal characteristics and the nutritional composition of the supplements will inform the implementation of prenatal BEP interventions. Methods and findings Individual participant data from 11 randomized controlled trials of prenatal BEP supplements (N = 12,549, with 5,693 in the BEP arm and 6,856 in the comparison arm) in low- and middle-income countries were used. The primary outcomes included GWG adequacy (%) and the estimated total GWG at delivery as continuous outcomes, and severely inadequate (<70% adequacy), inadequate GWG (<90% adequacy), and excessive GWG (>125% adequacy) as binary outcomes; all variables were calculated based on the Institute of Medicine recommendations. Linear and log-binomial models were used to estimate study-specific mean differences or risk ratios (RRs), respectively, with 95% confidence intervals (CIs) of the effects of prenatal BEP on the GWG outcomes. The study-specific estimates were pooled using meta-analyses. Subgroup analyses were conducted by individual characteristics. Subgroup analyses and meta-regression were conducted for study-level characteristics. Compared to the comparison group, prenatal BEP led to a 6% greater GWG percent adequacy (95% CI: 2.18, 9.56; p = 0.002), a 0.59 kg greater estimated total GWG at delivery (95% CI, 0.12, 1.05; p = 0.014), a 10% lower risk of severely inadequate GWG (RR: 0.90; 95% CI: 0.83, 0.99; p = 0.025), and a 7% lower risk of inadequate GWG (RR: 0.93; 95% CI: 0.89, 0.97; p = 0.001). The effects of prenatal BEP on GWG outcomes were stronger in studies with a targeted approach, where BEP supplements were provided to participants in the intervention arm under specific criteria such as low body mass index or low GWG, compared to studies with an untargeted approach, where BEP supplements were provided to all participants allocated to the intervention arm. Conclusions Prenatal BEP supplements are effective in increasing GWG and reducing the risk of inadequate weight gain during pregnancy. BEP supplementation targeted toward pregnant women with undernutrition may be a promising approach to delivering the supplements.
UR - http://www.scopus.com/inward/record.url?scp=85217223918&partnerID=8YFLogxK
U2 - 10.1371/journal.pmed.1004523
DO - 10.1371/journal.pmed.1004523
M3 - Article
AN - SCOPUS:85217223918
SN - 1549-1277
VL - 22
JO - PLoS Medicine
JF - PLoS Medicine
IS - 2
M1 - e1004523
ER -